Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (191-200 of 576) with videos related to

Pageof 58
Sort By:
Molecular Cancer Therapeutics|March 22, 2013
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancerRebekah L Zinn, Eric E Gardner, Luigi Marchionni, et al.
Nature Reviews. Clinical Oncology|March 11, 2020
Lineage plasticity in cancer: a shared pathway of therapeutic resistanceÁlvaro Quintanal-Villalonga, Joseph M Chan, Helena A Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and XenograftsJames H Laird, Benjamin H Lok, Jennifer Ma, et al.
Nature Reviews. Clinical Oncology|March 24, 2020
Publisher Correction: Lineage plasticity in cancer: a shared pathway of therapeutic resistanceÁlvaro Quintanal-Villalonga, Joseph M Chan, Helena A Yu, et al.
Journal of Cardiovascular Pharmacology|June 1, 1993
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imagingW Zierhut, M Rudin, E Robertson, et al.
NMR in Biomedicine|September 26, 2000
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRIT Reese, R Pórszász, D Baumann, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2014
SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell linesIrem Dogan, Shigeru Kawabata, Emily Bergbower, et al.
Molecular Cancer Therapeutics|November 8, 2014
Repurposing the antihelmintic mebendazole as a hedgehog inhibitorAndrew R Larsen, Ren-Yuan Bai, Jon H Chung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2026
Brief Report: Proposed clinical trial guidelines based on clinicopathological heterogeneity of metastatic pulmonary large cell neuroendocrine carcinoma (LCNEC)Noura J Choudhury, Emelie Gezelius, Andrea Arfe, et al.
NMR in Biomedicine|May 18, 2001
Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRIN Beckmann, C Gentsch, D Baumann, et al.
Pageof 58

Showing results (191-200 of 576) with videos related to

Sort By:
Pageof 58
Molecular Cancer Therapeutics|March 22, 2013
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancerRebekah L Zinn, Eric E Gardner, Luigi Marchionni, et al.
Nature Reviews. Clinical Oncology|March 11, 2020
Lineage plasticity in cancer: a shared pathway of therapeutic resistanceÁlvaro Quintanal-Villalonga, Joseph M Chan, Helena A Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
Talazoparib Is a Potent Radiosensitizer in Small Cell Lung Cancer Cell Lines and XenograftsJames H Laird, Benjamin H Lok, Jennifer Ma, et al.
Nature Reviews. Clinical Oncology|March 24, 2020
Publisher Correction: Lineage plasticity in cancer: a shared pathway of therapeutic resistanceÁlvaro Quintanal-Villalonga, Joseph M Chan, Helena A Yu, et al.
Journal of Cardiovascular Pharmacology|June 1, 1993
Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imagingW Zierhut, M Rudin, E Robertson, et al.
NMR in Biomedicine|September 26, 2000
Cytoprotection does not preserve brain functionality in rats during the acute post-stroke phase despite evidence of non-infarction provided by MRIT Reese, R Pórszász, D Baumann, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2014
SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell linesIrem Dogan, Shigeru Kawabata, Emily Bergbower, et al.
Molecular Cancer Therapeutics|November 8, 2014
Repurposing the antihelmintic mebendazole as a hedgehog inhibitorAndrew R Larsen, Ren-Yuan Bai, Jon H Chung, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2026
Brief Report: Proposed clinical trial guidelines based on clinicopathological heterogeneity of metastatic pulmonary large cell neuroendocrine carcinoma (LCNEC)Noura J Choudhury, Emelie Gezelius, Andrea Arfe, et al.
NMR in Biomedicine|May 18, 2001
Non-invasive, quantitative assessment of the anatomical phenotype of corticotropin-releasing factor-overexpressing mice by MRIN Beckmann, C Gentsch, D Baumann, et al.
Pageof 58